FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis - Michaeli, Christoph T.; Jürges, Hendrik; Michaeli, Daniel (The BMJ, 2023)
Gesehen am 04.07.2023